Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Sagan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- Brett Tighe - $21.45M in OKTA purchases and sales in the last 12 months
- Todd McKinnon - $20.47M in OKTA purchases and sales in the last 12 months
- Larissa Schwartz - $5.06M in OKTA purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Sagan?
Paul Sagan is a corporate insider, tracked as Director of Okta, Inc. (OKTA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul Sagan last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 2 filings going back to 2025.
